ETF comparison

IHI vs XLV

Both Healthcare.

iShares U.S. Medical Devices ETF · State Street Health Care Select Sector SPDR ETF

Holdings overlap

Weighted by ISIN/CUSIP
18.2 %

16 positions appear in both funds. Buying equal dollars of IHI and XLV would leave roughly 18.2% of each dollar exposed to the same underlying securities.

IHI only 81.7% Shared 18.2% XLV only 81.6%
In IHI only
31 positions
Shared
16 positions
In XLV only
44 positions

Side by side

IHI

iShares U.S. Medical Devices ETF

iShares · Healthcare

62 composite / 100
Expense ratio
0.38%
Net assets
$3.02B
TTM yield
0.49%
Top-10 conc.
74.5%
XLV

State Street Health Care Select Sector SPDR ETF

State Street · Healthcare

83 composite / 100
Expense ratio
0.080%
Net assets
$40.60B
TTM yield
1.60%
Top-10 conc.
59.1%

Sub-score comparison

62
Cost
92
85
Tax efficiency
82
77
Liquidity
100
8
Concentration
30
Tracking quality
IHI sub-score XLV

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

XLV is 30 bps cheaper than IHI. On a $100,000 position that's about $300/yr more in fees for IHI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IHI vs XLV.

Top shared holdings

16 shared in total
# Holding In IHI In XLV Overlap
1 ABBOTT LABORATORIES 16.98% 3.37% 3.37%
2 INTUITIVE SURGICAL, INC. 15.57% 3.09% 3.09%
3 STRYKER CORPORATION 10.76% 2.13% 2.13%
4 MEDTRONIC PUBLIC LIMITED COMPANY 4.62% 2.09% 2.09%
5 BOSTON SCIENTIFIC CORPORATION 4.28% 1.75% 1.75%
6 EDWARDS LIFESCIENCES CORPORATION 4.47% 0.88% 0.88%
7 IDEXX LABORATORIES, INC. 4.44% 0.85% 0.85%
8 BECTON, DICKINSON AND COMPANY 4.57% 0.84% 0.84%
9 RESMED INC. 4.43% 0.62% 0.62%
10 GE HEALTHCARE TECHNOLOGIES INC. 4.40% 0.61% 0.61%
11 DEXCOM, INC. 3.28% 0.46% 0.46%
12 STERIS PUBLIC LIMITED COMPANY 2.94% 0.41% 0.41%

Only in IHI

31 total
  • PENUMBRA, INC. 1.75%
  • GLOBUS MEDICAL, INC. 1.30%
  • MASIMO CORPORATION 1.10%
  • GLAUKOS CORPORATION 0.84%
  • TELEFLEX INCORPORATED 0.72%
  • ENVISTA HOLDINGS CORPORATION 0.56%
  • IRHYTHM HOLDINGS, INC. 0.52%
  • LIVANOVA PLC 0.47%
  • TRANSMEDICS GROUP, INC. 0.46%
  • INTEGER HOLDINGS CORPORATION 0.42%

Only in XLV

44 total
  • Eli Lilly & Co 13.74%
  • Johnson & Johnson 11.10%
  • AbbVie Inc 7.25%
  • Merck & Co Inc 5.63%
  • UnitedHealth Group Inc 4.62%
  • Amgen Inc 3.57%
  • Thermo Fisher Scientific Inc 3.48%
  • Gilead Sciences Inc 3.26%
  • Pfizer Inc 3.01%
  • Bristol-Myers Squibb Co 2.33%

Open IHI or XLV at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.